-
Entity
-
Company
-
Location
-
200 Barr Harbor Drive, Suite 400, West Conshohocken, Pennsylvania
-
Summary
-
The estimated value of insider holdings of Fairmount Funds Management LLC is at least $283 M dollars as of June 12, 2024. Fairmount Funds Management LLC is the Director of Apogee Therapeutics, Inc. and owns shares of Apogee Therapeutics, Inc. (APGE) stock worth about $151 M. Fairmount Funds Management LLC is the Director of Cogent Biosciences, Inc. and owns shares of Cogent Biosciences, Inc. (COGT) stock worth about $46.7 M. Fairmount Funds Management LLC is the Director of Dianthus Therapeutics, Inc. /DE/ and owns shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock worth about $43.1 M. Fairmount Funds Management LLC is the Director, 10%+ Owner of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $38.8 M. Fairmount Funds Management LLC is the Director of Spyre Therapeutics, Inc. and owns shares of Spyre Therapeutics, Inc. (AGLE) stock worth about $2.71 M.